Aberrant STAT signaling and T cell dysregulation define a targetable pediatric sepsis endotype
BACKGROUND: Sepsis is a leading cause of morbidity and mortality in critically ill children, yet heterogeneous immune responses complicate the development of targeted therapies and the host immune factors driving sepsis pathobiology remain unclear. METHODS: We integrated deep immune phenotyping, plasma proteomics, single-cell transcriptomics, and phosphoflow cytometry in a prospective cohort of 88 critically ill children to elucidate the mechanisms underlying immune heterogeneity. RESULTS: Unsupervised clustering of plasma cytokines identified three immunologic subgroups, including a high-severity group ("Group C") characterized by hypercytokinemia driven by IL-6 and IFN-γ. Group C exhibited distinct alterations in immune cell frequency and activation, with a strong association between hyperinflammatory cytokine signaling and lymphocyte dysfunction. Single-cell RNA sequencing revealed transcriptional signatures of T cell activation and metabolic stress, with suppression of a lymphoid protective gene program across CD8⁺ T cell subsets. Despite increased expression of activation markers, T cell receptor repertoire analysis revealed no dominant clonotypes, consistent with bystander activation. Phosphoflow cytometry demonstrated baseline STAT1/STAT3 hyperactivation in Group C CD8⁺ T cells, which failed to respond to αCD3/αCD28/αCD49d stimulation. CONCLUSIONS: These findings define an IL‑6/IFN‑γ-driven endotype of T cell dysfunction in pediatric sepsis and highlight the JAK/STAT axis as a rational target for immunomodulatory therapy. FUNDING: K12HD047349, K23GM159013, K08AI135091, R01HD095976, Thrasher Research Foundation, Burroughs Wellcome Fund CAMS, Immune Deficiency Foundation, Primary Immune Deficiency Treatment Consortium, Barbara Brodsky Foundation, CHOP Research Institute.
Authors
- Montana Knight (ORCID: https://orcid.org/0000-0002-5229-4122)
- Lisa Forbes Satter (ORCID: https://orcid.org/0000-0001-9402-1934)
- Sarah E. Henrickson (ORCID: https://orcid.org/0000-0001-5569-4132)
- Robert B. Lindell (ORCID: https://orcid.org/0000-0002-6334-4973)
- Hossein Fazelinia (ORCID: https://orcid.org/0000-0003-3074-5698)
- Nuala J. Meyer (ORCID: https://orcid.org/0000-0003-4597-5584)
- Steven M. Holland (ORCID: https://orcid.org/0000-0003-3207-5464)
- Apoorva Babu (ORCID: https://orcid.org/0000-0003-3661-5261)
- Peyton Conrey (ORCID: https://orcid.org/0000-0001-7766-9878)
- Jenna Bergerson (ORCID: https://orcid.org/0000-0001-9122-4998)
- Jennifer W. Leiding (ORCID: https://orcid.org/0000-0002-7573-9390)
- Rui Feng (ORCID: https://orcid.org/0000-0003-4151-7228)
- Ceire A. Hay (ORCID: https://orcid.org/0000-0003-2102-8769)
- Richard Tustin
- Sydney A. Sheetz
- Stephen T. Famularo
- J C Fitzgerald
- N Yehya
- Jose S Campos Duran (ORCID: https://orcid.org/0000-0003-3344-7733)
- E. John Wherry
- Edward M. Behrens (ORCID: https://orcid.org/0000-0002-4603-7963)
- Deanne M. Taylor
- Alexandra F. Freeman
- David T. Teachey (ORCID: https://orcid.org/0000-0001-7373-8987)
- Mark W. Hall
- Andrea A. Mauracher
- Teresa Arroyo
- Samir U. Sayed (ORCID: https://orcid.org/0000-0003-4981-5721)
- Scott L. Weiss
Institutions
- Nationwide Children's Hospital (US)
- Children's Hospital of Philadelphia (US)
- Johns Hopkins University (US)
- Thomas Jefferson University (US)
- Baylor College of Medicine (US)
- Johns Hopkins Medicine (US)
- Parker Institute for Cancer Immunotherapy (US)
- National Institute of Allergy and Infectious Diseases (US)
- Texas Children's Hospital (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Journal of Clinical Investigation
- Published
- 2026-06-09
- DOI
- https://doi.org/10.1172/jci202867
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Burroughs Wellcome Fund
- Immune Deficiency Foundation
- Thrasher Research Fund
- National Institute of General Medical Sciences
- National Institute of Allergy and Infectious Diseases